Comarit (Cabozantinib, L01XE26) is a tyrosine kinase inhibitor, indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC). Cabozantinib (Cometriq, L01XE26) inhibits the kinase activity of certain receptors that are responsible for various pathological processes such as oncogenesis, metastasis, tumor angiogenesis, drug resistance, and maintenance of the tumor microenvironment. Comarit is the Cometriq generic. Comarit manufactured by Genvio Pharma Limited. Genvio is one of the top anticancer medicine manufacturer in Bangladesh. Comarit is the generic brand of Cometriq (Cabozantinib) at an affordable price.
|Product Name||COMARIT 20|
|Generic Name||Cabozantinib Malate INN 20 mg Capsule|
|FDA Approved Indications||Comarit (Cabozantinib) indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC).|
|Packaging||Each commercial box contains 3×10’s capsules in Alu-Alu blister pack.|
|Prescribing Information||COMARIT 20 (PDF)|